THE EFFICIENCY AND COST OF LOCAL HYPOTENSIVE THERAPY IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA IN CIS
Objective: to determine the efficiency of the treatment for glaucoma and its accompanying costs in patients with II-III stages of open-angle glaucoma. Material and methods. The multicenter study which was conducted by 35 investigators in 29 clinical centers in 4 CIS countries from December 2013 to April 2014 took into account the results of the treatment of 115 patients (187 eyes) with glaucoma. The cost and «cost-effectiveness» of the intraocular pressure (IOP)-lowering treatment were calculated with the account of IOP-level compensation. Results. The average cost-effectiveness was 13.94 ± 0.66 rubles/day, which was comparable to the theoretical cost of the treatment but 32 % exceeded the price that patients actually paid for the treatment. As for the monotherapy with prostaglandin preparations and the fixed combination of beta-adrenoblocker and prostaglandin analogue (BB + PG), the difference between the actual price and cost-effectiveness was 44 %. At the same time, this difference in the application of the fixed combination of beta-adrenoblocker and carbonic anhydrase inhibitor (BB + CAI) made up 64 %. Conclusion. It is cheaper to achieve a controlled IOP level in the application of the fixed combination BB + PG compared to the BB + CAI fixed combination treatment.